Seroprevalence of hepatitis E virus in HIV-infected patients in China

Hang Zeng; Lin Wang; Peng Liu; Lingjie Liao; Ling Wang; Yiming Shao

doi:10.1097/QAD.0000000000001585

Seroprevalence of hepatitis E virus in HIV-infected patients in China

AIDS. 2017 Sep 10;31(14):2019-2021. doi: 10.1097/QAD.0000000000001585.

Authors

Hang Zeng¹, Lin Wang, Peng Liu, Lingjie Liao, Ling Wang, Yiming Shao

Affiliation

¹ aDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center bState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China. *Hang Zeng and Lin Wang are cofirst authors.

PMID: 28692547
DOI: 10.1097/QAD.0000000000001585

Abstract

: The seroprevalence of hepatitis E virus (HEV) in HIV-infected patients in China has never been reported. Thus, anti-HEV in HIV-infected patients recruited in five provinces in China was tested. The seroprevalence of HEV was 39.7%, which was higher than that in the general population (23.5%). HEV infection might be a frequent cause of hepatitis in HIV-infected patients.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

China / epidemiology
HIV Infections / complications*
Hepatitis Antibodies / blood*
Hepatitis E / epidemiology*
Hepatitis E virus / immunology*
Humans
Seroepidemiologic Studies

Substances

Hepatitis Antibodies